Back

Assessment and contributing factors of adequate endothelization after drug-eluting stent implantation

29 August 2026 (08:15 - 08:40)
Organised by: Logo
Congress Presentation Part of: Precision cardiology by and beyond optical coherence tomography: integrating imaging, artificial intelligence, and biomarkers for plaque assessment Optical Coherence Tomography ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Masami Nishino

Osaka Rosai Hospital, Sakai (Japan)

3 More presentations in this session

Presentation thumbnail
Artificial intelligence-based analysis of stent malapposition and expansion from intracoronary optical coherence tomography
Mr X. Gu (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
A “foundation model” for precision coronary plaque phenotyping: integration of multi-modal imaging, laboratory, and clinical data via contrastive learning
Doctor S. Andreaggi (Boston, US)
Abstract Slides Video
Presentation thumbnail
The association between non-Lp(a)-ApoB / Lp(a) ratio and plaque vulnerability according to lipid oxidation status
Doctor T. Ishigaki (Ishinomaki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Precision cardiology by and beyond optical coherence tomography: integrating imaging, artificial intelligence, and biomarkers for plaque assessment

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
In vivo assessment of neointimal proliferation after drug-eluting stent implantation; comparison between findings using by coronary angioscopy and optical coherence tomography.
29 August 2025
thumbnail
Congress Presentation
Coronary porcine studies of mechanical, morphometric, and physiological performance based on OCT /angiography of CD31‑endothelial‑mimetic coating stent, drug-eluting stent and bare metal stent
29 August 2026
thumbnail
Congress Presentation
A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI
29 August 2026
thumbnail
Congress Presentation
VASCRAFT: a novel tissue-engineered human vascular graft for coronary artery bypass grafting (CABG)
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources